Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

Thieblemont, C; Howlett, S; Casasnovas, RO; Mounier, N; Perrot, A; Morschhauser, F; Fruchart, C; Daguindau, N; van Eygen, K; Oberic, L; Bouabdallah, R; Pica, GM; Nicolas-Virezelier, E; Abraham, J; Fitoussi, O; Snauwaert, S; Eisenmann, JC; Lionne-Huyghe, P; Bron, D; Tricot, S; Deeren, D; Gonzalez, H; Costello, R; Le Du, K; da Silva, MG; Grosicki, S; Trotman, J; Catalano, J; Caballero, D; Greil, R; Cohen, AM; Gaulard, P; Roulin, L; Takeshita, K; Casadebaig, ML; Tilly, H; Coiffier, B

View this publication in the PUBMED database